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Summary
Actin filaments that serve as ‘‘rails’’ for the myosin-based
transport of membrane organelles [1–4] continuously turn
over by concurrent growth and shortening at the opposite
ends [5]. Although it is known that dynamics of actin
filaments is essential for many of the actin cytoskeleton
functions, the role of such dynamics in myosin-mediated
organelle transport was never studied before. Here, we
addressed the role of turnover of actin filaments in the myo-
sin-based transport ofmembraneorganelles by treatingcells
with the drugs that suppress actin-filament dynamics and
found that such a suppression significantly inhibited organ-
elle transport along the actin filaments without inhibiting
their intracellular distribution or the activity of the myosin
motors. We conclude that dynamics of actin filaments is es-
sential for myosin-based transport of membrane organelles
and suggest a previously unknown role of actin-filament
dynamics in providing the ‘‘rails’’ for continuous organelle
movement resulting in the increased distances traveled by
membrane organelles along the actin filaments.
Results and Discussion
To address the role of dynamics of actin filaments in myosin-
based transport of membrane organelles, we used Xenopus
melanophores as an experimental system [6]. The major func-
tion of melanophores is fast redistribution of pigment granules,
which aggregate at the cell center or redisperse uniformly
throughout the cytoplasm [6]. Although pigment aggregation
is exclusively microtubule dependent, dispersion combines
kinesin-driven transport of granules along the radial microtu-
bules and myosin-driven transport along the randomly ar-
ranged actin filaments [7–9]. Treatment of melanophores with*Correspondence: rodionov@nso.uchc.edu
6These authors contributed equally to this workmicrotubule-depolymerizing drugs followed by application of
pigment-dispersion stimuli provides an established experi-
mental system for studying the actin component of the
organelle transport [7].
To test the hypothesis that dynamics of actin filaments is
important for actin-mediated organelle transport, we exam-
ined pigment aggregation and dispersion in melanophores
treated with the actin-stabilizing drug jasplakinolide [10]. For
reducing the possibility of nonspecific effects of the drug
treatment, jasplakinolide was taken at a low concentration
(1 mM) [11] and applied for a short period of time (5 min). We
found that whereas aggregation of pigment granules (a solely
microtubule-dependent process) occurred with normal kinet-
ics, the rate of pigment dispersion (a process that combines
microtubule-based and actin-based transport) was signifi-
cantly inhibited in jasplakinolide-treated cells (Figure 1A, and
Movies S1–S4 available online), suggesting that stabilization
of actin filaments by jasplakinolide specifically affects the
actin-filament-based component of pigment transport.
To study the effects of jasplakinolide specifically on the
actin-based transport in the absence of the microtubule com-
ponent, we examined the effects of actin-filament-stabilizing
drugs on the movement of pigment granules in melanophores
treated with a microtubule-depolymerizing drug nocodazole
[7]. Consistent with previous observations [7], pigment gran-
ules continuously moved in nocodazole-treated cells in the
presence of pigment-dispersion stimuli, as seen in a light
microscope. Shortly after the application of jasplakinolide to
such cells (5 min), visible movement of pigment granules
dramatically decreased (Movies S5 and S6), suggesting that
jasplakinolide treatment inhibited granule movement along
the actin filaments. To quantify this effect, we plotted averaged
squared distances traveled by individual pigment granules
over time (Figure 1B) and used the 2D diffusion model to quan-
titatively characterize pigment-granule movement by calculat-
ing the diffusion coefficients (defined as the slope of the curve
of the averaged square distance over time, approximated to
a straight line) [12] for granule movement under different
conditions. Jasplakinolide treatment resulted in a decrease
of the diffusion-coefficient value by w8-fold compared to
untreated control cells (to 0.48 3 1023mm2/s, compared to
4.03 3 1023 mm2/s in the control). A significant inhibition was
also observed when instead of jasplakinolide treatment, cells
were injected with phalloidin, an actin-filament-stabilizing
drug chemically distinct from jasplakinolide [13]. Phalloidin
injection resulted in the diffusion-coefficient value dropping
to 0.91 3 1023 mm2/s compared to the 3.79 3 1023 mm2/s
seen in control mock-injected cells (Figure 1B). Thus, the effect
of actin-filament-stabilizing drugs on pigment transport is in-
deed related to the inhibition of dynamics of actin filaments
and not to the specific chemical properties of jasplakinolide.
It was previously shown that inhibition of intracellular myo-
sin Va by overexpression of a dominant-negative truncated
construct of myosin Va results in a complete inhibition of
actin-based pigment granule transport [9]. To compare the
levels of this inhibition with those seen in jasplakinolide, we
measured actin-based pigment granule movement in cells
transfected with the dominant-negative myosin construct
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1582Figure 1. Treatment of Melanophores with Actin
Filament-Stabilizing Drugs Inhibits Transport of
Pigment Granules
(A) Phase-contrast images of melanophores
treated with melatonin to induce pigment aggre-
gation (top row) or with melanocyte-stimulating
hormone to induce pigment dispersion (bottom
row) in the absence (left panel) or in the presence
(right panel) of jasplakinolide (1 mM). Pairs of
images in each panel show the same cells before
or 10 min after hormone treatment. Whereas
pigment aggregation occurred with a normal
kinetics, the rate of pigment dispersion was
significantly inhibited in jasplakinolide-treated
cells. Numbers indicate time in min; The scale
bar represents 20 mm.
(B) Quantification of actin-dependent movement
of pigment granules measured in cells with
disrupted cytoplasmic microtubules. Plots
show changes with time of averaged squared
distances traveled by pigment granules from
the starting point in control cells (black squares),
cells treated with jasplakinolilde (1 mM) for 5 min
(red circles), cells injected with phalloidin solu-
tion (100 mM; purple triangles), buffer-injected
cells (blue diamonds), GFP-overexpressing cells
(green triangles), or cells overexpressing domi-
nant-negative myosin Va construct (MST-GFP;
dark blue triangles). Treatment of cells with
jasplakinolide or microinjection with phalloidin
solution reduces the movement of pigment gran-
ules to the levels seen in melanophores overex-
pressing dominant-negative myosin Va. Error
bars indicate mean 6 SD.
(C) Decomposition of the trajectories of pigment-
granule movement in cells with disrupted micro-
tubules into linear (blue) and random diffusion-
like displacements (green) through multiscale
trend analysis in control (two top trajectories)
and jasplakinolide-treated (two bottom trajecto-
ries) cells. The lengths of linear segments of the
trajectories that correspond to actin-based runs
are significantly shorter in jasplakinolide-treated
cells. See also Movies S1–S6.and treated with nocodazole to disrupt microtubules and
found that in such cells, actin-based transport was reduced
to the levels similar to jasplakinolide treatment (Figure 1B,
MST-GFP; 0.393 1023 mm2/s; Figure 1B). Therefore, treatment
of cells with the actin-stabilizing drug jasplakinolide indeed
caused a substantial decrease in the transport of pigment
granules along the actin filaments, suggesting that dynamics
of actin filaments is required for such transport.
Although the diffusion-coefficient value is an accepted pa-
rameter to describe the overall displacement of pigment gran-
ules over time [14], it does not allow measurements of the
specific velocity and length of linear particle excursions that
correspond to the transport events along the actin filaments.
Rather, it encompasses all types of pigment-granule behavior,
including pauses between the runs and random displacement
of pigment granules in a motor-independent way. This limita-
tion makes it difficult to evaluate the effect of stabilization of
actin filaments specifically on the myosin-driven actin-based
transport component rather than the overall displacement of
the pigment in the cell. To specifically evaluate this effect, we
performed a detailed analysis of pigment-granule trajectories
by decomposing pigment-granule movement into linear excur-
sions along actin filaments and random, diffusion-like move-
ment, using multiscale trend analysis (MTA) [15] (Figure 1C).
We found that, consistentwith the results of visual observationsand diffusion-coefficient measurements, jasplakinolide treat-
ment substantially (w3-fold) reduced the lengths of linear actin
runs and the amount of time that pigment granules spent
moving along the actin filaments (Table 1). The velocity of ac-
tin-based movement was also reduced to some extent. Thus,
actin-dependent movement of pigment granules was indeed
inhibited in cells with stabilized actin filaments.
Several types of control experiments were performed to
validate this result. First, to confirm that our jasplakinolide
Table 1. Parameters of Actin-Based Motion of Pigment Granules and
Lysosomes
Pigment Granules Lysosomes
Control JSP Control JSP
Number of
examined runs
767 504 559 532
Duration of
runs (min)
0.21 6 0.01 0.10 6 0.01 0.14 6 0.01 0.10 6 0.01
Length of
runs (mm)
0.41 6 0.02 0.13 6 0.01 0.34 6 0.01 0.21 6 0.01
Velocity or
runs (mm/min)
2.05 6 0.04 1.40 6 0.04 2.60 6 0.05 2.40 6 0.05
Time spent
on actin (%)
66 6 0.5 24 6 0.5 68 6 0.8 42 6 0.7
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1583Figure 2. Jasplakinolide Treatment Stabilizes Actin Filaments, but Does Not
Significantly Change Their Organization, or the Levels of Actin Polymer in
the Cytoplasm
(A and B) FRAP analysis of the turnover rates of actin filaments in control and
jasplakinolide-treated cells.
(A) Sets of successive images of the bleached zones in control nontreated
(left) or jasplakinolide-treated (right) cells. The scale bar represents 10 mm.
(B) Quantification of fluorescence recovery in the bleached zones located at
approximately equal distances from the cell center and cell margin in the
areas of the cytoplasm capable of supporting actin-based transport. Black
squares represent control cells; gray circles represent jasplakinolide-
treated cells. Error bars represent SEM for measurements in ten different
cells. Recovery of actin fluorescence is significantly faster in control than
in jasplakinolide-treated cells. Numbers shown on (A) indicate time after
the photobleaching.
(C) Distribution of actin fluorescence in the same cell before (middle) or
5 min after (right) application of jasplakinolide. For the labeling of actin fila-
ments, the cell was injected with rhodamine-actin 2 hr prior to acquisition of
images. The left, phase-contrast image that shows distribution of pigmenttreatment indeed stabilized actin filaments in melanophores,
we studied actin dynamics in the absence and presence of
jasplakinolide in cells microinjected with rhodamine-labeled
actin, using fluorescence recovery after photobleaching
(FRAP). The recovery of actin fluorescence after bleaching of
a small zone in the cytoplasm was much slower in jasplakino-
lide-treated than in control cells, as evidenced from the
quantification of actin fluorescence in the bleached zone (Fig-
ure 2 and Movies S7 and S8). We conclude that, as expected,
jasplakinolide treatment indeed resulted in the inhibition of
actin-filament dynamics.
Second, we examined the possibility that inhibition of
pigment-granule transport upon jasplakinolide treatment
could be explained by the reorganization of actin cytoskeleton
caused by the drug. To address this, we examined the organi-
zation of actin filaments before and after jasplakinolide treat-
ment by light-microscopy imaging of live cells microinjected
with rhodamine-labeled actin and by electron microscopy of
platinum replicas of regions of fixed cells treated with myosin
subfragment 1 (S1) to decorate actin filaments. Live imaging of
the same cells before and 5 min after the application of the
drug indicated that jasplakinolide treatment did not cause
significant changes in the distribution of actin fluorescence
(Figure 2C). Electron microscopy of platinum replicas demon-
strated that the overall distribution of actin filaments (Fig-
ure 2D) as well as their local density (determined as the total
length of actin filaments per area in ten different fields of
view, Figure 2E) were similar in jasplakinolide-treated and
control untreated melanophores. Therefore, brief exposure
of melanophores to the low concentrations of jasplakinolide
used in our experiments did not lead to significant changes
in the organization of actin filaments in the treated cells, sug-
gesting that the inhibition of actin-based transport of pigment
granules observed in jasplakinolide-treated cells could not be
explained by changes in actin-filament organization.
Finally, we tested the possibility that jasplakinolide sup-
pressed transport of pigment granules along actin filaments
by inhibiting the activity of pigment-granule-bound myosin
motors. To do this, we isolated pigment granules from melano-
phores and compared their movement along the actin fila-
ments, fluorescently labeled with rhodamine-phalloidin, in
the presence or absence of jasplakinolide in an in vitro motility
assay. In both control and jasplakinolide-treated samples,
pigment granules frequently attached to actin filaments and
moved along them (Figure 3A and Movies S9 and S10). In
both samples, these transport events occurred with similar
frequencies and at similar velocities (3.47 6 0.17 and 3.93 6
0.12 mm/min, in the control and jasplakinolide-treated
granules in the same cell; jasplakinolide treatment does not significantly
change the distribution of actin fluorescence. The scale bar represents
20 mm.
(D) Electron micrographs of platinum replicas of cytoplasmic regions
located at approximately equal distances from the cell center and cell
margin in control nontreated (left) and a jasplakinolide-treated (right) mela-
nophores. The characteristic rope-like appearance of the actin filaments
(inserts), which allowed their identification in electron micrographs, is ex-
plained by their decoration with the S1 subfragment of myosin during the
preparation of samples for electron microscopy [7]. The S1-decorated actin
filaments are highlighted in yellow. Jasplakinolide treatment did not signif-
icantly change actin-filament distribution. The scale bar represents 0.5 mm.
(E) Quantification of the actin-filament density by measuring the length of
actin filaments in electron micrographs of control nontreated and jasplaki-
nolide-treated cells. Error bars represent SEM for measurements in ten
different cells. Jasplakinolide treatment does not significantly affect the
density of actin filaments. See also Movies S7 and S8.
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1584Figure 3. Jasplakinolide Does Not Affect Myosin-
Driven Movement of Isolated Pigment Granules
along Actin Filaments Examined in In Vitro Motil-
ity Assay
(A) Successive images of fluorescently labeled
actin filaments and pigment granules acquired
in the absence (top panel) or in the presence
(bottom panel) of jasplakinolide (1 mM). In both
control and jasplakinolide-containing samples,
pigment granules often attached to actin fila-
ments and moved along them, thereby indicating
that jasplakinolide does not significantly inhibit
myosin-based transport of pigment granules.
Numbers indicate time in s. The scale bar repre-
sents 0.5 mm.
(B) Frequency histograms of movement veloci-
ties of pigment granules along the actin filaments
in vitro in the absence (left) or presence (right) of
jasplakinolide. In both the presence or the ab-
sence of jasplakinolide, the movement velocities
peaked atw3 mm/min, thereby indicating that the
drug has no detectable effect on the activity of
myosin Va. See also Movies S9 and S10.samples, respectively, Figure 3B). To rule out the possibility
that in our motility assays actin filaments bound jasplakinolide
and therefore removed it from solution, we also examined
movement of pigment granules along the jasplakinolide-stabi-
lized actin filaments assembled from rhodamine actin. We
found that in these experimental conditions, pigment granules
moved with velocity 3.69 6 0.17 mm/min, similarly to control
samples. Therefore, suppression of pigment-granule transport
in jasplakinolide-treated cells cannot be explained by inhibi-
tion of myosin Va activity or its capacity to drive organelle
transport along the actin filaments.
Thus, the experiments shown above demonstrate that
inhibition of dynamics of actin filaments inhibits organelle
transport along them without affecting the density or distribu-
tion of the actin-filament tracks or the properties of the myosin
motor. A possible explanation for this effect is that continuous
growth and shortening of actin filaments creates temporal
openings between the adjacent actin filaments and removes
physical obstacles in the granule paths to prevent their
trapping in the actin-filament network. If this is the case,
stabilization of actin filaments should affect the overall ability
of granules to move through the cytoplasm, including their
microtubule-based transport. Although our initial experiments
show that jasplakinolide treatment does not affect global
pigment redistribution along microtubules during pigment ag-
gregation (Figure 1A) and therefore argue against such a possi-
bility, it is still possible that local changes in microtubule-based
transport are observed in jasplakinolide-treated cells. To
address this possibility, we examined the effect of stabilization
of actin filaments by jasplakinolide on the parameters of
bidirectional movement of individual pigment granules along
microtubules during pigment aggregation. Measurement and
analysis of individual granule displacement showed that
suppression of actin-filament dynamics by jasplakinolide did
not affect the rates or durations of uninterrupted runs of pig-
ment granules along microtubules, or the duration of pauses
(Figure S1). Thus, stabilization of actin filaments during jaspla-
kinolide treatment does not induce pigment granule trapping.To further test the trapping ability of stabilized actin fila-
ments, we tested whether jasplakinolide treatment affects
the diffusion of soluble cytoplasmic particles that are not
a cargo for myosin-driven movement and quantified the move-
ment of fluorescent latex beads microinjected into melano-
phores in the presence or absence of the drug (see Movies
S11 and S12). We found that diffusion coefficients of latex
beads in the presence or absence of jasplakinolide were very
similar (0.41 3 1023, and 0.39 3 1023 mm2/s, respectively).
Therefore stabilization of actin filaments does not restrain
the movement of cytoplasmic particles regardless of the basis
of their motility. The results of these experiments suggest that
actin-filament dynamics facilitates myosin-based transport of
pigment granules by a specific mechanism that affects the
ability of the actin tracks themselves to support organelle
movement.
To test whether this actin-dynamics-dependent transport
mechanism applies to the transport of organelles different
from pigment granules, we tested the effect of stabilization
of actin filaments on the transport of lysosomes labeled with
fluorescent LysoTracker dye (see Movies S13 and S14). Similar
to pigment granules, lysosomes move along actin tracks by
means of a myosin motor [16]. Decomposition of lysosome
trajectories with the MTA showed that linear actin runs were
shorter and the time spent on actin was reduced in jasplakino-
lide-treated cells. Although the movement of lysosomes was
affected to a lesser extent than the movement of pigment gran-
ules, presumably because of a smaller contribution of actin-
based movement to the transport of lysosomes, inhibition of
the lysosome motility was substantial (Table 1). Therefore, the
requirement for actin dynamics is not a specific property of
the pigment-granule transport but appears to be a universal
property for the actin-based movement of membrane organ-
elles.
Our results suggest that the actin-based component of the
organelle transport involves a population of dynamic actin
filaments that lose actin subunits off the minus (‘‘pointed’’)
ends and add them to the plus (‘‘barbed’’) ends. Analysis of
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average rate of growth of actin filaments in the cytoplasm is
w4.3 mm/min, which is greater than velocities of movement
of pigment granules or lysosomes along the actin filaments
(Table 1). Such faster filament growth compared to the velocity
of the myosin-based movement suggests that myosin motors
that move organelles to the growing ‘‘barbed’’ ends of actin fil-
aments never reach the ends of transport tracks. Thus, growth
of actin filaments should significantly increase the distances
traveled by organelles by increasing the effective transport
track’s length (Figure 4). Inhibition of actin dynamics inhibits
addition of subunits to the ‘‘barbed’’ ends of the actin fila-
ments, blocking the elongation of the actin tracks ahead
of the moving organelles. An organelle that reaches the end
of such a nondynamic track would be forced to stop or switch
to an adjacent actin track. For this switching to occur, how-
ever, the density of actin filaments in the cytoplasm should
be sufficient for each organelle to be in close proximity (touch-
ing distance) to multiple actin filaments at a time. Examination
of the stereo EM images of melanophores (see Figure S2) indi-
cates, however, that despite an apparently high density (Fig-
ure 2D) most of the actin filaments do not make close contact
with pigment-granule surface, suggesting that switching of or-
ganelles to adjacent actin tracks is far more infrequent than
their continued transport along the same filament. Therefore,
organelles arriving at the ends of stable actin tracks would
be forced to come off into the cytoplasm and stop moving.
On a mass scale, such inhibition is expected to slow down
the entire actin-based movement in the cytoplasm, as seen
in our experiments.
Our hypothesis about the role of actin dynamics in intracel-
lular transport sheds light onto the general mechanisms of
transport of all types of membrane organelles that use myosin
motors for the movement along the actin filaments. Actin
filaments are highly dynamic in all types of eukaryotic cells ex-
amined so far. The published half-times for the turnover of ac-
tin filaments in mammalian cells vary from a few seconds to
several minutes (see e.g., [17–20].), and are therefore in about
the same range as in melanophores (w2 min; Figure 2B). This
suggests that membrane organelles, such as mitochondria
[21], synaptic vesicles [22], and secretory granules [23], always
move along the dynamic actin filaments. Most myosins trans-
port cargoes to the ‘‘barbed’’ ends of actin filaments with the
Figure 4. Role of Actin Dynamics in the Myosin-Based Transport of Pigment
Granules
Myosin Va moves pigment granule toward the plus ends of actin filaments,
which grow at the same time. Therefore, growth of actin filaments should
increase distance traveled by pigment granule along them.velocities comparable to the actin-filament growth rates at
physiological actin concentrations [2, 5]; therefore, the fila-
ment growth should be a significant factor that determines
the distances traveled by membrane organelles in the cyto-
plasm. Analysis of the role of actin dynamics in the transport
of specific types of membrane organelles is an exciting new
direction for the future experiments.
It is widely accepted that actin-based movement of
membrane organelles and cytoplasmic particles involves two
independent mechanisms. Whereas some organelles, such
as pigment granules, are transported along the actin filaments
by myosin motors [2], others are pushed through the cyto-
plasm by the actin filaments that assemble at the surface
and often form the characteristic ‘‘comet tails’’ [24–28]. The
actin-filament-assembly-dependent transport mechanism is
responsible for the movement of intracellular pathogens [25,
27, 29] and organelles such as endosomes [28] or mitochon-
dria [24]. In this mechanism, the assembly of actin filaments
plays a central role because it provides the driving force for
the transport. Our data show for the first time that dynamics
of actin filaments is indispensable for the myosin-based trans-
port as well. Therefore, dynamic behavior is a fundamental
property of actin filaments, which plays an essential role in
all types of the actin-dependent intracellular transport
mechanisms.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, three
figures, and fourteen movies and can be found with this article online at
http://www.current-biology.com/supplemental/S0960-9822(08)01242-6.
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